Hakan Ertem

Dr. Hakan Ertem


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2024 in Journal of Hand Surgery (European Volume)
Verified
Journal Article
Closed access
HEHakan Ertem
Hakan Ertem
SSSefa Selük
Sefa Selük
OOOsman Orman
Osman Orman
KÖKahraman Öztürk
Kahraman Öztürk
MBMehmet Baydar
Mehmet Baydar
In this retrospective study, we evaluated the impact of tumour-related and surgical factors on the recurrence of giant cell tumours of tendon sheath. A total of 95 patients were treated at our institution between February 2012 and March 2021. We identified the factors most likely to be associated with recurrence from evaluation of classification, neurovascular invasion, bone erosion and joint invasion. Based on these criteria, we identified 49 patients with a high risk of recurrence. Of the 95 patients, recurrence was observed in 17. Among the 49 patients classified as high-risk, 13 were found to have recurrence. This study demonstrates that recurrence is more common in the high-risk patient group. Level of evidence: IV

26 February 2024 in Istanbul Medical Journal
Verified
Journal Article
Closed access
BABarış Acar
Barış Acar
AŞAyşe Şencan
Ayşe Şencan
MBMehmet Baydar
Mehmet Baydar
EÜEthem Ayhan Ünkar
Ethem Ayhan Ünkar
HEHakan Ertem
Hakan Ertem
BUBaki Avşar Uzun
Baki Avşar Uzun

13 March 2026 in Injury
Verified
Journal Article
Closed access
HEHakan Ertem
Hakan Ertem
IAIbrahim Faruk Adiguzel
Ibrahim Faruk Adiguzel
HÖHüseyin Utku Özdeş
Hüseyin Utku Özdeş
OAOkan Aslantürk
Okan Aslantürk
KEKadir Ertem
Kadir Ertem

5 February 2026 in Acta Orthopaedica et Traumatologica Turcica
Verified
Journal Article
Open access
PDF file
IŞİbRahim Muhittin Şener
İbRahim Muhittin Şener
TOTAHİR OZTURK
TAHİR OZTURK
CACengiz Aldemir
Cengiz Aldemir
HEHakan Ertem
Hakan Ertem
KYKamil Yamak
Kamil Yamak
EZEyup Cagatay Zengin
Eyup Cagatay Zengin
Objective: This study aimed to compare the clinical and radiological results of scaphocapitate fusion (SCF) and capitohamate fusion (CHF) combined with lunate excision in advanced Kienböck’s disease. Methods: Patients over 18 years of age who were in stages IIIB-IIIC according to the Lichtman classification, and who had at least 1 year of follow-up, were included in the study. All patients had unilateral disease. Patients were divided into 2 groups according to whether they had CHF or SCF. The range of motion (ROM) and grip strength of the operated and contralateral active wrist joint were measured. Radiological evaluation of the severity of the disease was determined preoperatively using Lichtman staging. Preoperative and postoperative carpal height ratios (CHRs) were measured on anteroposterior radiographs. The presence of osteoarthritis was evaluated. Functional outcome was assessed using the Disability of the Arm, Shoulder, and Hand (DASH) and Visual Analogue Scale (VAS) scores. Results: The mean age of the 27 patients (12 CHF and 15 SCF) was 32.5 years. There was no statistically significant difference between the 2 groups in terms of demographic characteristics, Lichtman stages, and mean follow-up time. No difference between the groups regarding ROM, grip strength, VAS, and DASH scores could be found. The preoperative and postoperative CHRs were compared, and no difference was found between the groups. Conclusion: Although SCF has some advantages over CHF regarding joint ROM and clinical scores, no difference was found between the groups (clinically and radiologically). Both SCF and CHF combined with lunate excision seem to be effective in the treatment of advanced Kienböck’s disease in the mid-term. Cite this article as: Sener İM, Ozturk T, Aldemir C, et al. Lunatum excision and limited intercarpal fusion in advanced Kienb.ck’s disease: scaphocapitate versus capitohamate fusion. Acta Orthop Traumatol Turc. 2026, 60 (1), 0270, doi:10.5152/j.aott.2026.25270.

1 June 2023 in TOTBID Dergisi
Verified
Journal Article
Closed access
MBMehmet Baydar
Mehmet Baydar
HEHakan Ertem
Hakan Ertem
EÜEthem Ayhan Ünkar
Ethem Ayhan Ünkar

30 April 2026 in Journal of Orthopedics Research and Rehabilitation
Verified
Journal Article
Closed access
HÖHüseyin Utku Özdeş
Hüseyin Utku Özdeş
EEEmre Ergen
Emre Ergen
OTOğuzhan Tok
Oğuzhan Tok
KEKadir Ertem
Kadir Ertem
HEHakan Ertem
Hakan Ertem
IÇipek balıkçı çiçek
ipek balıkçı çiçek
Aims: Among cartilage-derived tumors in the hand, osteochondroma is the second most common benign lesion after enchondromas. Bizarre parosteal osteochondromatous proliferation (BPOP) is particularly rare in the hand and may be confused with malignant processes. This study presents the outcomes of surgically treated exophytic benign bone masses. The aim is to differentiate between these two lesions, which are very similar clinically, radiologically, and histopathologically. Methods: Nine patients who underwent surgery due to a mass in the hand, with a histopathological diagnosis of osteochondroma-BPOP, were included in the study. Surgeries were performed under axillary anesthesia by a single surgeon certified in hand surgery. The demographic data of the patients, characteristics of the mass, and associated clinical findings were recorded. Functional outcomes at the final outpatient follow-up after mass excision were assessed using VAS and q-DASH scores. Surgical complications and recurrence were also investigated. Results: The average age of the patients participating in the study was 40 years (range: 14-64 years). The average follow-up period after surgery was 30 months (range: 8-120 months). A total of 9 patients underwent surgery due to a palpable mass, with histopathologically confirmed diagnoses reporting 6 cases of solitary osteochondroma and 3 cases of BPOP. During the follow-up period, 1 patient developed a recurrent mass, and this patient with a diagnosis of BPOP underwent reoperation. Clinically, all patients experienced a resolution of preoperative complaints, and significant improvements were observed in clinical scores. Conclusion: Symptomatic classical osteochondroma and BPOP lesions cause concern for patients. Successful outcomes can be achieved through surgical excision. However, after excluding malignancy, it is important to differentiate between these lesions. It will be beneficial to be aware of the high recurrence rates in cases considered similar to osteochondroma excision, such as BPOP lesions, and to maintain a diligent follow-up.